Tech Company Financing Transactions

Virobay Funding Round

Virobay closed a $8 million Series B funding round on 7/17/2014. Investors included AbbVie Biotech Ventures, Alta Partners and Perceptive Advisors.

Transaction Overview

Company Name
Announced On
7/17/2014
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1360 Willow Rd. 100
Menlo Park, CA 94025
USA
Email Address
Overview
Virobay Inc is a virtual pharmaceutical development company. We find promising small molecule compounds in early or late leadoptimization and complete all necessary studies required toachieve a clinical proof-of-concept.
Profile
Virobay LinkedIn Company Profile
Social Media
Virobay Company Twitter Account
Company News
Virobay News
Facebook
Virobay on Facebook
YouTube
Virobay on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Booth
  Robert Booth LinkedIn Profile  Robert Booth Twitter Account  Robert Booth News  Robert Booth on Facebook
VP - Manufacturing
Anantha Sudhakar
  Anantha Sudhakar LinkedIn Profile  Anantha Sudhakar Twitter Account  Anantha Sudhakar News  Anantha Sudhakar on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/17/2014: PredictionIO venture capital transaction
Next: 7/17/2014: SalutarisMD venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary